Clinical Trial Update: SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPC [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/Phase 2 clinical trial evaluating SSTR2 imaging with [68Ga]Ga-DOTA-TOC PET/CT in nasopharyngeal carcinoma; recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• [68Ga]Ga-DOTA-TOC (Ga-DOTA-TOC)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Nasopharyngeal Carcinoma (NPC) | Phase 1, Phase 2 | Status: RECRUITING